USA - NASDAQ:ALGN - US0162551016 - Common Stock
The current stock price of ALGN is 144.49 USD. In the past month the price increased by 11.33%. In the past year, price decreased by -35.41%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.85 | 14.26B | ||
| SOLV | SOLVENTUM CORP | 12.44 | 12.81B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 24.03 | 5.29B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.95 | 3.63B | ||
| ICUI | ICU MEDICAL INC | 17.99 | 3.54B | ||
| HAE | HAEMONETICS CORP/MASS | 14.94 | 3.46B | ||
| XRAY | DENTSPLY SIRONA INC | 6.95 | 2.19B | ||
| UFPT | UFP TECHNOLOGIES INC | 28.46 | 1.89B | ||
| NEOG | NEOGEN CORP | 21.77 | 1.42B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.35B | ||
| EMBC | EMBECTA CORP | 4.87 | 831.73M | ||
| BVS | BIOVENTUS INC - A | 13.05 | 636.64M |
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,945 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
ALIGN TECHNOLOGY INC
410 North Scottsdale Road, Suite 1300
Tempe ARIZONA 95134 US
CEO: Joseph M. Hogan
Employees: 20945
Phone: 14084701000
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,945 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
The current stock price of ALGN is 144.49 USD. The price increased by 4.53% in the last trading session.
ALGN does not pay a dividend.
ALGN has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
ALIGN TECHNOLOGY INC (ALGN) currently has 20945 employees.
ALIGN TECHNOLOGY INC (ALGN) has a market capitalization of 10.47B USD. This makes ALGN a Large Cap stock.
The outstanding short interest for ALIGN TECHNOLOGY INC (ALGN) is 3.59% of its float.
ChartMill assigns a technical rating of 3 / 10 to ALGN. When comparing the yearly performance of all stocks, ALGN is a bad performer in the overall market: 84.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to ALGN. ALGN gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months ALGN reported a non-GAAP Earnings per Share(EPS) of 9.67. The EPS increased by 3.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.04% | ||
| ROA | 7.04% | ||
| ROE | 11.18% | ||
| Debt/Equity | 0 |
24 analysts have analysed ALGN and the average price target is 179.63 USD. This implies a price increase of 24.32% is expected in the next year compared to the current price of 144.49.
For the next year, analysts expect an EPS growth of 11.17% and a revenue growth 0.42% for ALGN